GFGunnar Fimland

Gunnar Fimland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gunnar Fimland has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Jon Nissen-Meyer

    Department of Biochemistry, University of Oslo, Blindern, 0316 Oslo, Norway1

    6 shared publications
  • Line Johnsen

    Department of Biochemistry, University of Oslo, Oslo, Norway

    2 shared publications
  • Vincent G. H. Eijsink

    Department of Chemistry and Biotechnology, Agricultural University of Norway, Ås, Norway2

    2 shared publications
  • Håvard Hildeng Hauge

    Department of Biochemistry, University of Oslo, Oslo, Norway

    1 shared publication
  • Ilia Brondz

    Department of Biochemistry, University of Oslo, Oslo, Norway

    1 shared publication
  • Ingolf F. Nes

    Department of Biochemistry, University of Oslo, Oslo,1 and MATFORSK, Norwegian Food Research Institute,2 Norwegian Crop Research Institute,3 and Department of Chemistry and Biotechnology, Agricultural University of Norway,4 Ås, Norway

    1 shared publication

Latest Publications

  • Comparative studies of immunity proteins of pediocin-like bacteriocins

    by Gunnar Fimland, Vincent G. H. Eijsink, Jon Nissen-Meyer

    Genes encoding pediocin-like bacteriocins are usually co-transcribed with a gene encoding a cognate immunity protein. To investigate the functionality and specificity of immunity proteins, immunity genes belonging to the bacteriocins curvacin A, enterocin A, enterocin P, leucocin A, pediocin PA-1 and sakacin P, as well as a putative immunity gene, orfY, were expressed in three bacteriocin-sensitive lactic acid bacteria (Lactobacillus sake, Carnobacterium piscicola and Enterococcus faecalis). The transformed indicator strains, each containing one of the immunity genes, were tested for sensitivity towards seven different purified bacteriocins (curvacin A, enterocin A, enterocin P, leucocin A, leucocin C, pediocin PA-1 and sakacin P). Cross-immunity was observed almost exclusively in situations where either the bacteriocins or the immunity proteins belonged to the same sequence-based subgroup. In a few cases, the functionality of immunity proteins was strain-dependent; e.g. the leucocin A immunity gene provided immunity to enterocin A, pediocin PA-1 and leucocin A in Ent. faecalis, whereas in the other two indicators, this gene provided immunity to leucocin A only. The orfY gene, which is transcribed without a cognate bacteriocin, was shown to encode a functional immunity protein that expands the bacteriocin resistance of the strain possessing this gene. The results show that the bacteriocin sensitivity of a lactic acid bacterium strain can depend on (1) the presence of immunity genes in connection with its own bacteriocin production, (2) the presence of extra immunity genes and (3) more general properties of the strain such as the membrane composition or the presence of receptors.


  • Mutational analysis of the role of charged residues in target-cell binding, potency and specificity of the pediocin-like bacteriocin sakacin P

    by Maja Kazazic, Jon Nissen-Meyer, Gunnar Fimland

    The significance of charged residues for the target-cell binding, potency and specificity of pediocin-like bacteriocins has been studied by site-directed mutagenesis of sakacin P. Most of the charged residues are located in the N-terminal half, which is thought to mediate the initial binding of these bacteriocins to target cells through electrostatic interaction. All the mutated peptides in which the net positive charge was reduced by one (by replacing a charged residue with threonine) exhibited reduced binding to target cells and a 2–15-fold reduction in potency. The least deleterious of these mutations was the removal of the positive charge in position 8 (H8T). This mutation was, in fact, less deleterious than the conservative His to Lys mutation, indicating that the positive charge in position 8 per se is not of major importance. Somewhat more deleterious was the removal of positive charges at the N- and C-terminal ends (K1T, K43T). Most deleterious was the elimination of the positive charge at positions 11 and (but to a lesser extent) 12, demonstrating the importance of the cationic patch in the middle of the N-terminal half of pediocin-like bacteriocins. Mutated peptides in which the net positive charge was increased by one were also constructed. Some of these exhibited increased cell binding and a potency that was the same as (44K, i.e. an extra positive charge at the C-terminus), or somewhat greater (T20K) than, that of sakacin P, whereas others (0K, i.e. an extra positive charge at the N-terminus) had reduced potency. Sakacin P contains only one negatively charged residue (Asp17). This negative charge and its orientation in space were crucial for activity, since the Asp to Asn mutation and (especially) the conservative Asp to Glu mutation were deleterious. Mutations that made the peptide less cationic had, overall, less effect on the potency toward the Carnobacterium piscicola strain than on the potency toward the three other strains tested, whereas the opposite was the case for mutations that made the peptide more cationic. Thus, charged residues in the N-terminal half may – apparently via the initial electrostatic binding of the bacteriocin to target cells – influence the target-cell specificity.


  • Open Access

    Rapid Two-Step Procedure for Large-Scale Purification of Pediocin-Like Bacteriocins and Other Cationic Antimicrobial Peptides from Complex Culture Medium

    by Marianne Uteng, Håvard Hildeng Hauge, Ilia Brondz, Jon Nissen-Meyer, Gunnar Fimland

    A rapid and simple two-step procedure suitable for both small- and large-scale purification of pediocin-like bacteriocins and other cationic peptides has been developed. In the first step, the bacterial culture was applied directly on a cation-exchange column (1-ml cation exchanger per 100-ml cell culture). Bacteria and anionic compounds passed through the column, and cationic bacteriocins were subsequently eluted with 1 M NaCl. In the second step, the bacteriocin fraction was applied on a low-pressure, reverse-phase column and the bacteriocins were detected as major optical density peaks upon elution with propanol. More than 80% of the activity that was initially in the culture supernatant was recovered in both purification steps, and the final bacteriocin preparation was more than 90% pure as judged by analytical reverse-phase chromatography and capillary electrophoresis.


  • Engineering Increased Stability in the Antimicrobial Peptide Pediocin PA-1

    by Line Johnsen, Gunnar Fimland, Vincent Eijsink, Jon Nissen-Meyer

    Pediocin PA-1 is a food grade antimicrobial peptide that has been used as a food preservative. Upon storage at 4°C or room temperature, pediocin PA-1 looses activity, and there is a concomitant 16-Da increase in the molecular mass. It is shown that the loss of activity follows first-order kinetics and that the instability can be prevented by replacing the single methionine residue (Met31) in pediocin PA-1. Replacing Met by Ala, Ile, or Leu protected the peptide from oxidation and had only minor effects on bacteriocin activity (for most indicator strains 100% activity was maintained). Replacement of Met by Asp was highly deleterious for bacteriocin activity.


  • A C-Terminal Disulfide Bridge in Pediocin-Like Bacteriocins Renders Bacteriocin Activity Less Temperature Dependent and Is a Major Determinant of the Antimicrobial Spectrum

    by Gunnar Fimland, Line Johnsen, Lars Axelsson, May B. Brurberg, Ingolf F. Nes, Vincent G. H. Eijsink, Jon Nissen-Meyer

    Several lactic acid bacteria produce so-called pediocin-like bacteriocins that share sequence characteristics, but differ in activity and target cell specificity. The significance of a C-terminal disulfide bridge present in only a few of these bacteriocins was studied by site-directed mutagenesis of pediocin PA-1 (which naturally contains the bridge) and sakacin P (which lacks the bridge). Introduction of the C-terminal bridge into sakacin P broadened the target cell specificity of this bacteriocin, as illustrated by the fact that the mutants were 10 to 20 times more potent than the wild-type toward certain indicator strains, whereas the potency toward other indicator strains remained essentially unchanged. Like pediocin PA-1, disulfide-containing sakacin P mutants had the same potency at 20 and 37°C, whereas wild-type sakacin P was approximately 10 times less potent at 37°C than at 20°C. Reciprocal effects on target cell specificity and the temperature dependence of potency were observed upon studying the effect of removing the C-terminal disulfide bridge from pediocin PA-1 by Cys→Ser mutations. These results clearly show that a C-terminal disulfide bridge in pediocin-like bacteriocins contributes to widening of the antimicrobial spectrum as well as to higher potency at elevated temperatures. Interestingly, the differences between sakacin P and pediocin PA-1 in terms of the temperature dependency of their activities correlated well with the optimal temperatures for bacteriocin production and growth of the bacteriocin-producing strain.